Critical Path for Alzheimer’s Disease Founded in 2008, the Critical Path for Alzheimer’s Disease (CPAD) enhances regulatory decision-making tools to advance drug deve
Biomarker Data Repository C-Path’s Biomarker Data Repository (BmDR) advances qualification of novel biomarkers as drug development tools. The initial pilo
